Sponsor:
Immuneering Corporation
Code:
NCT07562152
Conditions
Pancreatic Cancer
Pancreatic Cancer Metastatic
PDAC
PDAC - Pancreatic Ductal Adenocarcinoma
Pancreatic Ductal Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Atebimetinib
GnP
mGnP
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-04. This information was provided to ClinicalTrials.gov by Immuneering Corporation on 2026-05-01.